Heading to #ASCO26? Reach out to Dr David Collingridge, Editor-in-Chief at @thelancetoncol.bsky.social, attending #ASCO26 🗓️ Attend the Global Oncology: A Workforce Crisis—A Lancet Oncology Commission session May 31, 2026, 4:30 PM-5:45 PM CDT #cancerworkforce meetings.asco.org/meetings/202...

Heading to #ESTRO26? Attend our Top Clinical Trials session, May 17 Reach out to Cheryl Lai, Deputy Editor at @thelancetoncol.bsky.social, attending #ESTRO and say hello!

🎉Proud to share our first online article by @nathaliealbert.bsky.social & colleagues that was presented at #NMN2026 @nmnsymposium.bsky.social www.thelancet.com/action/showF...

@thelancetoncol.bsky.social news desk: www.thelancet.com/journals/lan...

🎧Our May podcast: Cheryl Lai is joined by Fred Saad (Montreal) to discuss pain and HRQOL outcomes from the ARANOTE trial in metastatic hormone-sensitive prostate cancer 📊Article: www.thelancet.com/journals/lan... Spotify: open.spotify.com/episode/1EGt... Apple: podcasts.apple.com/us/podcast/t...

Join IARCWHO for the #IARC60 conference in Lyon, France, May 19-21. Learn from your peers from around the world how you can improve cancer prevention in your setting. Register: iarc2026conf.iarc.who.int/en/registrat...

🆕Our May issue is live! 📊Articles: #breastcancer, #prostatecancer, and #softtissuesarcoma 📑Reviews: Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer from the EORTC–ESTRO OligoCare consortium Read here: thelancet.com/issue/S1470-...

Cancer prevention isn’t the same in every country, but every local breakthrough advances global progress. Join IARCWHO for the #IARC60 conference. Learn from your peers from around the world how you can improve cancer prevention in your setting. Register: iarc2026conf.iarc.who.int/en/registrat...

🆕 Introducing The Lancet Regional Health – Eastern Mediterranean, a new #goldopenaccess journal promoting the advancement of clinical practice and health policy in the Eastern Mediterranean. Discover the new addition to The Lancet Group at: spkl.io/63328AFIyw#goldopenaccess#medsky

This month's podcast: James Nagarajah on [177Lu]-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study 🎧 Listen & subscribe! Spotify: open.spotify.com/show/3JOj0Cl... Apple: podcasts.apple.com/us/podcast/t...

✏️Our Editorial: The promise of telesurgery in oncology thelancet.com/journals/lan...

🆕Our April issue is live! 📊Articles: #NSCLC, #bladdercancer, #melanoma, #prostatecancer, #breastcancer 📰Reviews: A PSOGI–ESGO–ISSPP Lyon consensus & OPTIMISE-AR recommendations for visualising PROs Cover: Spaceflight as a cancer research catalyst www.thelancet.com/issue/S1470-...

🔴Online now: UK NICE 2026 guideline for the diagnosis and management of kidney cancer Read here: thelancet.com/journals/lan...

🎧NEW podcast Our editor-in-chief, Ali Landman talked with Cheryl Lai, deputy editor of @thelancetoncol.bsky.social about our journal, its scope, the team. She also shared her takeaways from the European Congress of Radiology #ECR. #RadSky

@thelancetoncol.bsky.social are proud to be media partners of #IARC@60 Conference #IARCWHO has selected the successful authors from the ~1300 abstracts submitted from all over the world. Register here: iarc2026conf.iarc.who.int/en/registrat...

In our March Editorial, we discuss England's National Cancer Plan, launched on Feb 4. The plan sets out ambitious targets, but will these be met? Read England's National Cancer Plan: hollow promises? here:🖱️https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00077-X/fulltext#f10

🎧 Our March podcast: We talk to Dylan Graetz and Erica Kaye @stjuderesearch.bsky.social about qualitative research in oncology thelancet.com/multimedia/p... Follow In Conversation With Spotify: open.spotify.com/show/3JOj0Cl... Apple: podcasts.apple.com/us/podcast/t...

🆕Our March issue is live! 📊Articles: #prostatecancer, #breastcancer, #melanoma, and #brachytherapy 📰Reviews: #ESTRO concensus on RT for more efficacious novel anticancer drugs + a expert consensus on oligometastatic pancreatic cancer www.thelancet.com/issue/S1470-...

A clinical trial from @thelancetoncol.bsky.social explores whether advanced PET imaging improves outcomes over standard MRI for guiding re-irradiation in recurrent glioblastoma. It aligns with our journal's focus on how imaging influence treatment & patient lives 🔓https://bit.ly/thelancet-lanonc-642

We are happy to be media partners with the European Association for Cancer Research (EACR) for the #EACR2026 Congress: Innovative Cancer Science in Budapest, Hungary; June 8–11, 2026 Submit your abstract by March 4, 2026: 2026.eacr.org

🔴Online now: Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised #prostatecancer (HYPO-RT-PC): 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial thelancet.com/journals/lan...

On #WorldCancerDay, stay up to date with the latest oncology content published across The Lancet Group. Explore our Specialty Collection: spkl.io/63327AsDNU

🆕 Greater transparency for oncology clinical trials reporting Chief Editors of The Lancet’s specialty journals discuss enhanced scrutiny in the reporting of oncology clinical trials Read here: thelancet.com/journals/lan...

✏️February's Editorial - Cancer: another casualty of geopolitical unrest? We discuss the deprioritisation of health care during geopolitical instability www.thelancet.com/journals/lan...

🆕Our Feb issue is live! 📉Articles: #NSCLC, #glioblastoma, #prostatecancer, #oesophagealcancer, and #coloncancer 📰Reviews: International Multidisciplinary Consensus Group for Malignant Spinal Cord Compression AND ReCOG consensus on multiple courses of RT thelancet.com/issue/S1470-...

🆕 “In this Viewpoint, we argue that trusted, hyperlocal, and globally present CHWs are a largely overlooked workforce in tackling the climate crisis, despite already doing work in adapting to and mitigating climate change.” Read the full Viewpoint now ➡️ www.thelancet.com/journals/lan...

Join our webinar on Feb 4, Improving Outcomes for Children with Serious Illness through Applied Qualitative Research Hosted by @stjuderesearch.bsky.social in collaboration with @thelancetoncol.bsky.social@thelancethaem.bsky.social @eclinicalmed.bsky.social stjudeglobal.zoom.us/meeting/regi...

As part of The Lancet Group’s partnership with IARC WHO for the #IARC60 Cancer Research into Action Conference, 19-21 May, 2026, @eclinicalmed.bsky.social will be publishing a best of special issue of conference abstracts Submit your abstract by 19 Jan iarc2026conf.iarc.who.int/en/abstracts...

@thelancetoncol.bsky.social, @thelancetph.bsky.social, @eclinicalmed.bsky.social are excited to partner with IARC for: #IARC60 Cancer Research into Action Conference Lyon, France, 19-21 May Submit your abstract by 19 Jan: iarc2026conf.iarc.who.int/en/abstracts... For more: iarc2026conf.iarc.who.int

🔴Online: Aumolertinib as adjuvant therapy in resected EGFR-mutated #NSCLC (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial 📉Article thelancet.com/journals/lan... ✏️Comment thelancet.com/journals/lan...

Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial spkl.io/63327AmhOT

🔴Online now: Cilta-cel in lenalidomide-refractory #multiplemyeloma (CARTITUDE-4): an updated analysis including OS from an open-label, multicentre, randomised, phase 3 trial thelancet.com/journals/lan...

🔴Online first: A new Comment from Clare Turnbull and colleagues on the PATHFINDER2 study of GRAIL's Galleri multicancer detection blood test thelancet.com/journals/lan...

✏️Our Jan 2026 Editorial: Cancer consequences of the HIV funding crisis "Beyond the already devastating impact on the global burden of HIV, the disruptions seen in 2025 could have consequences beyond HIV and AIDS alone..." www.thelancet.com/journals/lan...

🆕Our Jan 26 issue! 📈Articles: #endometrialcancer, #NSCLC, #glioma, #prostatecancer, #oesophagealcancer, #pancreaticcancer 📄Reviews: Framework for glioma surgery by PIONEER and RANO resect 🖱️https://www.thelancet.com/issue/S1470-2045(25)X0013-9 2026 cover artist: J Specht (IG@ ju.liaspecht)

🔴Online now: FET-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent #glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial www.thelancet.com/journals/lan...

The Call for Abstracts for the #IARC60 Cancer Research into Action Conference, in Lyon, France, 19-21 May, 2026 is open Deadline for abstract submission: 19 Jan 2026 iarc2026conf.iarc.who.int/en/abstracts... More info on the conference website: iarc2026conf.iarc.who.int

🎉We're excited to announce our partnership with #IARCWHO for the #IARC60 Cancer Research into Action Conference, in Lyon, France, 19-21 May, 2026!🎉 Accepting abstract until 19 Jan 2026 iarc2026conf.iarc.who.int/en/abstracts... More info on the conference website: iarc2026conf.iarc.who.int

@thelancetoncol.bsky.social's highlights from the San Antonio Breast Cancer Symposium 2025, #SABCS25 Including trials ELEVATE, ASCENT-07, EPIK-B5, and DETECT V thelancet.com/journals/lan...

✏️This month's Editorial: Making prostate cancer screening fit for purpose www.thelancet.com/journals/lan...

🚨Our Dec issue is live! - thelancet.com/issue/S1470-... 📊Articles: #lungcancer, #breastcancer, #hepatocellularcarcinoma, #rectalcancer, #glioma 📑Reviews including neurocognitive outcomes in patients with brain metastases AND SISAQOL-IMI consensus guidelines on PROs in trials

🔴Online: Artificial intelligence and radiologists in #pancreaticcancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study thelancet.com/journals/lan...

Check out London Global Cancer Week #LGCW2025, running Nov 24 to Nov 28. www.lgcw.org.uk/lgcw-2025/ It's a pleasure for @thelancetoncol.bsky.social to sponsor another year!

News 🗞️Government shutdown and Medicare changes impact cancer care in the USA, reported by Sharmila Devi www.thelancet.com/journals/lan... 🗞️More e-cigarette users than cigarette smokers for the first time in the UK, reported by Manjulika Das www.thelancet.com/journals/lan...

📊Online now: Effectiveness of NELSON versus PLCOm2012 #lungcancer screening eligibility criteria in Germany (HANSE): a prospective cohort study thelancet.com/journals/lan... ✏️Comment: Defining eligibility for lung cancer screening based on individual risk thelancet.com/journals/lan...

🚨 A new @thelancetoncol.bsky.social Commission warns of a growing “human crisis” in cancer. Despite scientific advances, many patients are not getting the compassionate, holistic support they need. Authors call for a shift towards more human-centered care: tinyurl.com/5x3rmnsv

🚨Our Nov issue is live - thelancet.com/issue/S1470-... 📊Articles: #breastcancer, #NSCLC, #prostatecancer, #melanoma 📰 Reviews: Tumour-infiltrating lymphocyte therapy in the era of genetic engineering AND AI for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO)

🆕Online: Overall survival assessment in cancer drug trials: a luxury or a necessity? Samuel X Stevens, @lateuwen.bsky.social, and Bishal Gyawali discuss the #FDA draft guidance on overall survival in randomised cancer drug trials thelancet.com/journals/lan...

🚨Our Oct issue is live - thelancet.com/issue/S1470-... 📈Articles: on #RCC, #SCLC, #NSCLC, #BladderCancer, #Myeloma, #PancreaticCancer, #EndometrialCancer, and #ThyroidCancer 📝Reviews: EU–CAYAS–NET recommendations for health-care transitions in young people beyond childhood cancer

No time to wait: resilience as a cornerstone for primary health care across Latin America and the Caribbean, a World Bank-PAHO Lancet Regional Health Americas Commission - The Lancet Regional Health – Americas www.thelancet.com/journals/lan...